Idorsia AG Aktie

Allschwil, Switzerland – May 23, 2024Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting

Ad hoc announcement pursuant to Art. 53 LR

Allschwil, Switzerland – May 21, 2024

Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2024.

Business highlights

Ad hoc announcement pursuant to Art. 53 LR

Bondholders approve amended terms of the 2024 convertible bonds

• The proposed amendments to the terms of the 2024 convertible bond have been approved by

Ad hoc announcement pursuant to Art. 53 LR

• The proposed consent fee will be increased to 8’000’000 Idorsia shares. All other matters as proposed on April 23, 2024, remain unchanged.
• The

Ad hoc announcement pursuant to Art. 53 LR

• A bondholder meeting will take place on May 6, 2024, to vote on proposals to amend the terms of the outstanding convertible bonds maturing on July 17

Ad hoc announcement pursuant to Art. 53 LR

• A bondholders meeting is expected to take place on April 30, 2024, to request the right to repay the bonds maturing in 2024, fully or partially in

• Guy Braunstein, currently Chief Medical Officer and member of the Idorsia Executive Committee, to retire at the end of March 2024

Allschwil, Switzerland – March 22, 2024Idorsia Ltd (SIX: IDIA)

Ad hoc announcement pursuant to Art. 53 LR

• TRYVIO™ (aprocitentan) is indicated for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult

Ad hoc announcement pursuant to Art. 53 LR

• Viatris and Idorsia will collaborate on the global development and commercialization of two Phase 3 assets, selatogrel and cenerimod.
• Idorsia to receive

Ad hoc announcement pursuant to Art. 53 LR

• CEO, Jean-Paul Clozel, to update on how Idorsia is being adapted for sustainable value creation
• The company is focused on extending the cash runway

Ad hoc announcement pursuant to Art. 53 LR

• Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of Directors
• Mathieu Simon to stand for re-election to the Board –

Ad hoc announcement pursuant to Art. 53 LR

Allschwil, Switzerland – May 21, 2024Idorsia Ltd (SIX: IDIA) today announced its financial results for the full year of 2023.

Business highlights

• Sale

Idorsia will publish its Full Year 2023 and Q1 2024 Financial Reporting on Tuesday May 21, 2024, at 07:00 CEST.

An investor conference call and webcast will be held to discuss the results on the

Ad hoc announcement pursuant to Art. 53 LR

• Unaudited Financial Status as of March 31, 2024, required for an upcoming bondholder meeting, now available on the company website
• Bondholder meeting

Ad hoc announcement pursuant to Art. 53 LR

Allschwil, Switzerland – March 18, 2024Idorsia Ltd (SIX: IDIA) today announced that it has successfully closed the transaction with Viatris Inc. (NASDAQ